ミネソタ州における神経芽腫の臨床試験
ミネソタ州内の拠点で、神経芽腫に関する9件の研究が参加者を募集しています。
ミネソタ州内の都市
公式研究テキスト（英語）
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
被験者募集中第3相
30歳以下 · 全性別 · 2026/10/02更新 · NCT06172296Biomarkers of Resiliency In Childhood Cancer Surgery
- Mayo Clinic, Rochester
被験者募集中観察研究
3歳〜25歳 · 全性別 · 2026/09/14更新 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Children's Hospital and Clinics of Minnesota, Minneapolis
被験者募集中第2相
22歳以下 · 全性別 · 2026/09/04更新 · NCT02559778Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
被験者募集中第3相
365 Days – 30 Years · 全性別 · 2026/08/25更新 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Children's Hospital and Clinics of Minnesota, Minneapolis
被験者募集中第2相
12 Months – 21 Years · 全性別 · 2026/08/12更新 · NCT05489887Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/05/19更新 · NCT04901702Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Masonic Cancer Center, University of Minnesota, Minneapolis
被験者募集中第2相
30歳以下 · 全性別 · 2025/10/21更新 · NCT02605421International PPB/DICER1 Registry
- Children's Minnesota, Minneapolis
被験者募集中観察研究健康なボランティア歓迎
0 Minutes – 100 Years · 全性別 · 2025/01/30更新 · NCT03382158ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。